Literature DB >> 6410795

Regional correlation of PET and CT in senile dementia of the Alzheimer type.

M J de Leon, A E George, S H Ferris, S Rosenbloom, D R Christman, C I Gentes, B Reisberg, I I Kricheff, A P Wolf.   

Abstract

Alzheimer disease is manifested by both widespread and regionally restricted brain changes, some of which have recently been identified in vivo with computed tomography (CT) and positron emission tomography (PET). This is a report of the regional correlation of CT and PET measurements in 19 carefully diagnosed subjects comprising 11 controls and eight patients with senile dementia of the Alzheimer type. Regional CT attenuation values did not discriminate between the two groups, but PET using 18F-2-deoxy-2-fluoro-D-glucose demonstrated significant regional reductions (range, 21%-28%) in glucose utilization in the Alzheimer group. PET measures were also more consistently related to cognitive decline. The correlation between CT structural measures and PET metabolic measures demonstrated consistent relations between widespread PET regions and CT changes in the thalamus, posterior limb of the internal capsule, and temporal lobes. However, CT changes in the frontal white matter, caudate nucleus, and anterior limb of the internal capsule were not related to any regional PET changes. These data support previous findings of temporal lobe involvement in Alzheimer disease and suggest the involvement of structures in the region of the third ventricle.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6410795      PMCID: PMC8335005     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  9 in total

Review 1.  Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.

Authors:  Suzanne M de la Monte
Journal:  Drugs       Date:  2017-01       Impact factor: 9.546

2.  Brain energy metabolism and neuroinflammation in ageing APP/PS1-21 mice using longitudinal 18F-FDG and 18F-DPA-714 PET imaging.

Authors:  Jatta S Takkinen; Francisco R López-Picón; Rana Al Majidi; Olli Eskola; Anna Krzyczmonik; Thomas Keller; Eliisa Löyttyniemi; Olof Solin; Juha O Rinne; Merja Haaparanta-Solin
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 3.  Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.

Authors:  Nishit Pathak; Sunil Kumar Vimal; Ishi Tandon; Lokesh Agrawal; Cao Hongyi; Sanjib Bhattacharyya
Journal:  Metab Brain Dis       Date:  2021-11-01       Impact factor: 3.584

Review 4.  Amyloid β-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression.

Authors:  D Allan Butterfield; Aaron M Swomley; Rukhsana Sultana
Journal:  Antioxid Redox Signal       Date:  2013-02-14       Impact factor: 8.401

5.  Dominantly inherited Alzheimer's disease: cerebral glucose metabolism.

Authors:  R J Polinsky; H Noble; G Di Chiro; L E Nee; R G Feldman; R T Brown
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-06       Impact factor: 10.154

6.  A computed tomography study of Alzheimer's disease by regional volumetric and parenchymal density measurements.

Authors:  Y Ichimiya; K Kobayashi; H Arai; K Ikeda; K Kosaka
Journal:  J Neurol       Date:  1986-06       Impact factor: 4.849

Review 7.  Biological Hallmarks of Cancer in Alzheimer's Disease.

Authors:  Kelly N H Nudelman; Brenna C McDonald; Debomoy K Lahiri; Andrew J Saykin
Journal:  Mol Neurobiol       Date:  2019-04-16       Impact factor: 5.590

Review 8.  The Causal Role of Lipoxidative Damage in Mitochondrial Bioenergetic Dysfunction Linked to Alzheimer's Disease Pathology.

Authors:  Mariona Jové; Natàlia Mota-Martorell; Pascual Torres; Victoria Ayala; Manuel Portero-Otin; Isidro Ferrer; Reinald Pamplona
Journal:  Life (Basel)       Date:  2021-04-25

Review 9.  Disentangling Mitochondria in Alzheimer's Disease.

Authors:  Ashu Johri
Journal:  Int J Mol Sci       Date:  2021-10-26       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.